中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2013年
23期
5-7
,共3页
高长花%余文珍%施红%刘宏波%郑远燕
高長花%餘文珍%施紅%劉宏波%鄭遠燕
고장화%여문진%시홍%류굉파%정원연
石斛合剂%糖尿病%OGTT%GLP-1%二甲双胍
石斛閤劑%糖尿病%OGTT%GLP-1%二甲雙胍
석곡합제%당뇨병%OGTT%GLP-1%이갑쌍고
Dendrobium compound%Diabetes%OGTT%Glucagon-like peptide-1%Metformin
目的:观察石斛合剂对糖尿病模型大鼠高糖负荷后胰高血糖素样肽-1(GLP-1)影响。方法:选取雌性Wistar大鼠随机分为正常对照组(n=10)和观察组(n=30),观察组予高脂高糖饲料喂养4周后腹腔注射小剂量链脲佐菌素(30mg/kg)造模,成模后随机分为模型组(n=10)、石斛合剂组(n=10)、二甲双胍组(n=10)。灌胃8周后,禁食10h行口服葡萄糖耐量(OGTT)试验,尾尖采血,用ELISA法检测血清GLP-1水平。结果:治疗8周后,与模型组比较,石斛合剂组的血糖降低(P<0.01),血清基础(0h)GLP-1水平明显升高(P<0.01),高糖负荷1h后,各组大鼠血清GLP-1水平均升高,石斛合剂组高于模型组与二甲双胍组(P<0.05),且与正常对照组无显著差异;高糖负荷2h后,石斛合剂组、正常对照组大鼠血清GLP-1水平均回落(组内比较,P<0.01),模型组与二甲双胍组则继续上升,各组间比较无差异;高糖负荷3h后,各组大鼠血清GLP-1水平均降低,石斛合剂组血清GLP-1水平较模型组高。结论:石斛合剂能有效的降低糖尿病模型大鼠血糖,增加血清GLP-1水平,其降糖机制可能是通过GLP-1及其降解产物信号途径介导。
目的:觀察石斛閤劑對糖尿病模型大鼠高糖負荷後胰高血糖素樣肽-1(GLP-1)影響。方法:選取雌性Wistar大鼠隨機分為正常對照組(n=10)和觀察組(n=30),觀察組予高脂高糖飼料餵養4週後腹腔註射小劑量鏈脲佐菌素(30mg/kg)造模,成模後隨機分為模型組(n=10)、石斛閤劑組(n=10)、二甲雙胍組(n=10)。灌胃8週後,禁食10h行口服葡萄糖耐量(OGTT)試驗,尾尖採血,用ELISA法檢測血清GLP-1水平。結果:治療8週後,與模型組比較,石斛閤劑組的血糖降低(P<0.01),血清基礎(0h)GLP-1水平明顯升高(P<0.01),高糖負荷1h後,各組大鼠血清GLP-1水平均升高,石斛閤劑組高于模型組與二甲雙胍組(P<0.05),且與正常對照組無顯著差異;高糖負荷2h後,石斛閤劑組、正常對照組大鼠血清GLP-1水平均迴落(組內比較,P<0.01),模型組與二甲雙胍組則繼續上升,各組間比較無差異;高糖負荷3h後,各組大鼠血清GLP-1水平均降低,石斛閤劑組血清GLP-1水平較模型組高。結論:石斛閤劑能有效的降低糖尿病模型大鼠血糖,增加血清GLP-1水平,其降糖機製可能是通過GLP-1及其降解產物信號途徑介導。
목적:관찰석곡합제대당뇨병모형대서고당부하후이고혈당소양태-1(GLP-1)영향。방법:선취자성Wistar대서수궤분위정상대조조(n=10)화관찰조(n=30),관찰조여고지고당사료위양4주후복강주사소제량련뇨좌균소(30mg/kg)조모,성모후수궤분위모형조(n=10)、석곡합제조(n=10)、이갑쌍고조(n=10)。관위8주후,금식10h행구복포도당내량(OGTT)시험,미첨채혈,용ELISA법검측혈청GLP-1수평。결과:치료8주후,여모형조비교,석곡합제조적혈당강저(P<0.01),혈청기출(0h)GLP-1수평명현승고(P<0.01),고당부하1h후,각조대서혈청GLP-1수평균승고,석곡합제조고우모형조여이갑쌍고조(P<0.05),차여정상대조조무현저차이;고당부하2h후,석곡합제조、정상대조조대서혈청GLP-1수평균회락(조내비교,P<0.01),모형조여이갑쌍고조칙계속상승,각조간비교무차이;고당부하3h후,각조대서혈청GLP-1수평균강저,석곡합제조혈청GLP-1수평교모형조고。결론:석곡합제능유효적강저당뇨병모형대서혈당,증가혈청GLP-1수평,기강당궤제가능시통과GLP-1급기강해산물신호도경개도。
Objetctive:To observe the effect of Dendrobium compound on serum glucagon-like peptide 1(GLP-1) level in type 2 diabetic rats after high sugar load. Methods:Select female Wistar rats in addition to the normal control group (n=10), give high sugar and high fat diet plus small dose of chain urea with streptozotocin (30mg/kg) to build mold, then randomly divided into model group (n=10), Dendrobium compound group, metformin group (n=10), respectively given saline, Dendrobium compound, metformin for 8 weeks. Fasted for 10h then take oral glucose tolerance test (OGTT), and serum GLP-1 level at each time point were also tested by ELISA. Result:After 8 weeks of treatment, compared with the model group, the BG level of Dendrobium compound group decreased (P<0.01), the level of GLP-1(0h) increased (P<0.01); after high sugar load (1h), the serum GLP-1 levels all increased, compared with model group and metformin group, the serum GLP-1 level of Dendrobium compound group increased (P<0.05), and no significant difference with the control group. After high sugar load (2h), Dendrobium compound group and normal control group serum GLP-1 levels were fallen back (within-group comparisons, P<0.01), and model group and metformin group continued to rise. After high sugar load (3h), the serum GLP-1 levels of all groups decreased. Conclusion:Dendrobium compound can significantly lower blood glucose, increase serum levels of GLP-1, its hypoglycemic mechanism may be mediated by glucagon-like peptide-1and its degradation product signaling pathway.